701 related articles for article (PubMed ID: 29691103)
1. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
[TBL] [Abstract][Full Text] [Related]
2. Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia.
Kim MW; Lim JY; Oh SH
Scand J Clin Lab Invest; 2017 Nov; 77(7):486-492. PubMed ID: 28678546
[TBL] [Abstract][Full Text] [Related]
3. Stratified and prognostic value of admission lactate and severity scores in patients with community-acquired pneumonia in emergency department: A single-center retrospective cohort study.
Zhou H; Lan T; Guo S
Medicine (Baltimore); 2019 Oct; 98(41):e17479. PubMed ID: 31593111
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
Chen Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
[TBL] [Abstract][Full Text] [Related]
5. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
[TBL] [Abstract][Full Text] [Related]
6. Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department.
Liu B; Yin Q; Chen YX; Zhao YZ; Li CS
Respir Med; 2014 Aug; 108(8):1204-13. PubMed ID: 24931899
[TBL] [Abstract][Full Text] [Related]
7. The value of procalcitonin level in community-acquired pneumonia in the ED.
Park JH; Wee JH; Choi SP; Oh SH
Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
[TBL] [Abstract][Full Text] [Related]
8. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the quick sequential organ failure assessment for predicting clinical outcomes among community-acquired pneumonia patients presenting in the emergency department.
Zhang X; Liu B; Liu Y; Ma L; Zeng H
BMC Infect Dis; 2020 Apr; 20(1):316. PubMed ID: 32349682
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Prediction Value of qSOFA, SOFA, and Admission Lactate in Septic Patients with Community-Acquired Pneumonia in Emergency Department.
Zhou H; Lan T; Guo S
Emerg Med Int; 2020; 2020():7979353. PubMed ID: 32322422
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R
Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of procalcitonin in community-acquired pneumonia.
Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
[TBL] [Abstract][Full Text] [Related]
13. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
14. Soluble thrombomodulin to evaluate the severity and outcome of community-acquired pneumonia.
Yin Q; Liu B; Chen Y; Zhao Y; Li C
Inflammation; 2014 Aug; 37(4):1271-9. PubMed ID: 24573987
[TBL] [Abstract][Full Text] [Related]
15. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.
Legramante JM; Mastropasqua M; Susi B; Porzio O; Mazza M; Miranda Agrippino G; D Agostini C; Brandi A; Giovagnoli G; Di Lecce VN; Bernardini S; Minieri M
PLoS One; 2017; 12(11):e0187702. PubMed ID: 29161297
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
Wang Y; Zhang S; Li L; Xie J
Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
[TBL] [Abstract][Full Text] [Related]
17. The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study.
Ito A; Ito I; Inoue D; Marumo S; Ueda T; Nakagawa H; Taki M; Nakagawa A; Tatsumi S; Nishimura T; Shiota T; Ishida T
Int J Infect Dis; 2020 Mar; 92():228-233. PubMed ID: 31981766
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
Menéndez R; Martínez R; Reyes S; Mensa J; Filella X; Marcos MA; Martínez A; Esquinas C; Ramirez P; Torres A
Thorax; 2009 Jul; 64(7):587-91. PubMed ID: 19131448
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of Charlson weighted index of comorbidities combined with sequential organ failure assessment score and procalcitonin in patients with sepsis].
Zhang X; Wang Q; Luo X; Lei Y; Huang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1335-1339. PubMed ID: 31898562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]